HIC1 reactivation in vitro and in vivo (in serially sorted primary AML blood blasts from DAC-treated patients) was more pronounced in haploinsufficient AML cells compared to cells with both HIC1 alleles present. Here, HIC1 is linked to acute myeloid leukemia.